Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Presentation Details:
Date:
Time: 10:15am ET (
Webcast Link: https://wsw.com/webcast/needham117/pho.ol/2531984
About the Needham Healthcare Conference
The 23rd Annual Needham Virtual Healthcare Conference will feature leading public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology, and Diagnostics sectors.
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com
For further information, please contact:
President and CEO
Photocure ASA
Email: [email protected]
CFO
Photocure ASA
Tel: +4745055000
Email: [email protected]
Vice President, Investor Relations
Photocure ASA
Tel: +1 202 280 0888
Email: [email protected]
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (
Tel: +47 91540000
Email: [email protected]
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:https://www.prnewswire.com/news-releases/photocure-to-participate-in-the-23rd-annual-needham-virtual-healthcare-conference-302109146.html
SOURCE Photocure
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ARTiSTORY's Four IAI Awards Signal a New Era for Cultural IP: From Licensing Assets to Building Global Cultural Brands
- JD 7Fresh Kitchen: Here Comes the “Wok Cooking Transformer”
- How to choose a funding firm in 2026: what traders should demand before paying for an evaluation
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share